Imexpharm Corporation

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
81,600 ^VND	+4.35%		+19.68%	+58.59%

Jul. 04	Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024	CI
May. 27	Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	CI

Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024

July 04, 2024 at 02:49 am EDT

Imexpharm Corporation announced Dividend Payout ratio 10% share based on par value (1 share will receive 1,000 VND) for the year 2023. Payment time is July 23, 2024. Ex-right date: July 11, 2024.

Record date: July 12, 2024.

Latest news about Imexpharm Corporation

Imexpharm Corporation Announces Dividend for the Year 2023, Payable on July 23, 2024	Jul. 04	CI
Imexpharm Corporation Appoints Tnrong Minh Hung, A Non-Executive Member of the Board of Directors, as A Member of the Audit Committee Under the Board of Directors	May. 27	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 19	CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors	Dec. 19	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-18	CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023	23-09-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-18	CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors	23-05-04	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-17	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-18	CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd.	22-08-24	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-18	CI
Imexpharm Corporation Announces Personnel Change	22-05-30	CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022	22-05-13	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-20	CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-18	CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-18	CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-01-19	CI
Imexpharm Corporation Reports Earnings Results for the Nine Months of 2020	20-10-29	CI

Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Imexpharm Corporation

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

81,600 VND

Average target price

68,848 VND

Spread / Average Target

-15.63%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
IMEXPHARM CORPORATION	+58.59%	237M
ELI LILLY AND COMPANY	+62.66%	841B
NOVO NORDISK A/S	+40.42%	625B
JOHNSON & JOHNSON	-4.37%	360B
MERCK & CO., INC.	+17.16%	327B
ABBVIE INC.	+9.87%	300B
ASTRAZENECA PLC	+15.66%	242B
NOVARTIS AG	+17.90%	227B
AMGEN INC.	+14.86%	174B
PFIZER, INC.	+0.45%	162B

Other Pharmaceuticals